Pharmacoeconomic evaluation of antidepressant therapies.

Managed care (Langhorne, Pa.)

Volumn 13, Issue 6 Suppl Depression, 2004, Pages 34-41

  Sarnes, Matthew W ^a   Frankum, Laura E ^a  

^a XCENDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; DRUG COST; ECONOMICS; HEALTH INSURANCE; PHARMACOECONOMICS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; UNITED STATES;

ANTIDEPRESSIVE AGENTS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; MANAGED CARE PROGRAMS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; UNITED STATES;

EID: 4344712578     PISSN: 10623388     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)